Nuvectis Pharma logo

Nuvectis Pharma share price today

(NVCT)

Nuvectis Pharma share price is $5.02 & ₹428.06 as on 27 Dec 2024, 2.30 'hrs' IST

$5.02

0.37

(7.96%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Nuvectis Pharma share price in Dollar and Rupees. Guide to invest in Nuvectis Pharma from India. Also see the sentimental analysis on Indian investors investing in Nuvectis Pharma. Get details on the Indian mutual funds that are investing in Nuvectis Pharma. Get Analyst recommendations and forecasts along with all the Nuvectis Pharma's financials.

Nuvectis Pharma share price movements

  • Today's Low: $4.55
    Today's High: $5.12

    Day's Volatility :11.18%

  • 52 Weeks Low: $4.44
    52 Weeks High: $12.10

    52 Weeks Volatility :63.31%

Nuvectis Pharma Returns

PeriodNuvectis Pharma IncIndex (Russel 2000)
3 Months
-24.76%
0.0%
6 Months
-26.54%
0.0%
1 Year
-45.74%
0.0%
3 Years
43.08%
-21.1%

Nuvectis Pharma Key Statistics

in dollars & INR

Previous Close
$4.65
Open
$4.72
Today's High
$5.1225
Today's Low
$4.55
Market Capitalization
$89.8M
Today's Volume
$38.7K
52 Week High
$12.1
52 Week Low
$4.44
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-140.0%

How to invest in Nuvectis Pharma from India?

It is very easy for Indian residents to invest directly in Nuvectis Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nuvectis Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nuvectis Pharma or NVCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nuvectis Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nuvectis Pharma shares which would translate to 0.170 fractional shares of Nuvectis Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nuvectis Pharma, in just a few clicks!

Returns in Nuvectis Pharma for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nuvectis Pharma investment value today

Current value as on today

₹60,901

Returns

₹39,099

(-39.1%)

Returns from Nuvectis Pharma Stock

₹41,424 (-41.42%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Nuvectis Pharma

-46%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Nuvectis Pharma on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -46% less investors are searching Nuvectis Pharma in the last 30 days versus the previous period.

Global Institutional Holdings in Nuvectis Pharma

  • Vanguard Group Inc

    1.56%

  • Baldwin Brothers Inc

    0.90%

  • BlackRock Inc

    0.43%

  • Geode Capital Management, LLC

    0.41%

  • Millennium Management LLC

    0.35%

  • Iridian Asset Management LLC

    0.29%

Analyst Recommendation on Nuvectis Pharma

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Nuvectis Pharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Nuvectis Pharma

What analysts predicted

Upside of 338.25%

Current:

$5.02

Target:

$22.00

Insights on Nuvectis Pharma

  • Price Movement

    In the last 7 days, NVCT stock has moved down by -0.9%
  • NVCT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 71.1%

Nuvectis Pharma Technicals Summary

Sell

Neutral

Buy

Nuvectis Pharma is currently in a neutral trading position according to technical analysis indicators.

Nuvectis Pharma Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nuvectis Pharma Inc
-11.93%
-26.54%
-45.74%
43.08%
43.08%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nuvectis Pharma Inc
NA
NA
NA
0.0
-1.4
-0.61
NA
0.58
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nuvectis Pharma Inc
Buy
$89.8M
43.08%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Nuvectis Pharma

Organization
Nuvectis Pharma
Employees
13
CEO
Mr. Ron Bentsur M.B.A.
Industry
Miscellaneous

Management People of Nuvectis Pharma

NameTitle
Mr. Ron Bentsur M.B.A.
Co-Founder, Chairman, CEO & President
Dr. Enrique Poradosu Ph.D.
Co-Founder, Executive VP, Chief Scientific & Business Officer
Mr. Shay Shemesh
Co-Founder, Executive VP, Chief Development & Operations Officer
Mr. Michael Carson CPA
Vice President of Finance

Important FAQs about investing in Nuvectis Pharma from India :

What is Nuvectis Pharma share price today?

Nuvectis Pharma share price today stands at $5.02, Open: $4.72 ; Previous Close: $4.65 ; High: $5.12 ; Low: $4.55 ; 52 Week High: $12.10 ; 52 Week Low: $4.44. The stock opens at $4.72, after a previous close of $4.65. The stock reached a daily high of $5.12 and a low of $4.55, with a 52-week high of $12.10 and a 52-week low of $4.44.

Can Indians buy Nuvectis Pharma shares?

Yes, Indians can invest in the Nuvectis Pharma (NVCT) from India.

With INDmoney, you can buy Nuvectis Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nuvectis Pharma at zero transaction cost.

How can I buy Nuvectis Pharma shares from India?

It is very easy to buy Nuvectis Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nuvectis Pharma be purchased?

Yes, you can buy fractional shares of Nuvectis Pharma with INDmoney app.

What are the documents required to start investing in Nuvectis Pharma stocks?

To start investing in Nuvectis Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nuvectis Pharma

Today’s highest price of Nuvectis Pharma (NVCT) is $5.12.

Today’s lowest price of Nuvectis Pharma (NVCT) is $4.55.

What is today's market capitalisation of Nuvectis Pharma

Today's market capitalisation of Nuvectis Pharma NVCT is 89.8M

What is the 52 Week High and Low Range of Nuvectis Pharma

  • 52 Week High

    $12.10

  • 52 Week Low

    $4.44

What are the historical returns of Nuvectis Pharma?

  • 1 Month Returns

    -11.93%

  • 3 Months Returns

    -26.54%

  • 1 Year Returns

    -45.74%

  • 5 Years Returns

    43.08%

Who is the Chief Executive Officer (CEO) of Nuvectis Pharma

Mr. Ron Bentsur M.B.A. is the current Chief Executive Officer (CEO) of Nuvectis Pharma.